Pharmaceutical Industry Information Portal

HomeTagsMerck

All posts by tag

Merck

Pfizer’s $11.6 billion purchase of Biohaven could lead to new biotech deals

Pfizer's $11.6 billion deal for migraine specialist Biohaven Pharmaceutical has kindled expectations on Wall Street that it may usher in more buyouts as cash-flush...

BMS, Merck enter into $2.3 billion partnership with Amphista to discover and develop small molecule protein degraders

Amphista Therapeutics, a global leader in the discovery and development of next generation targeted protein degradation (TPD) therapeutics, May 4th announced a strategic collaboration...

Congo declares new Ebola outbreak in north-western province

A new case of Ebola has been confirmed in northwestern Democratic Republic of Congo, prompting health authorities to enforce urgent containment measures just four...

Merck’s proposal to combine two top prostate cancer drugs fails

Merck (MSD) on Tuesday announced that it will stop the Phase 3 KEYLYNK-010 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with LYNPARZA, a...

U.S FDA approves drug to treat early breast cancer

AstraZeneca and Merck reported today, Lynparza (olaparib) has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated (gBRCAm) HER2-negative...

WHO includes oral antiviral molnupiravir in Covid-19 treatment guidelines

WHO has updated its living guidelines on COVID-19 therapeutics to include a conditional recommendation on molnupiravir, a new antiviral medicine. This is the first oral...
spot_img

Expert Articles

spot_img